{"transactions":[{"id":753018,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":41984,"kind":"person","name":"Eckhardt Sue Gail","position":1,"cik":"0001823769","reported_name":"Eckhardt Sue Gail","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-03T22:51:58.000Z","date":"2026-06-01","kind":"sale","planned":true,"acquired":false,"shares":9812,"price":50.14,"value":491973.68,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sales price. The shares of Exelixis, Inc. common Stock (\"Common Stock\") were sold in multiple transactions at prices ranging from $49.73 to $50.61. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 16,079 shares of Common Stock that will be issued to the Reporting Person upon vesting of restricted stock units (\"RSUs\"). Each RSU is the economic equivalent of one share of Common Stock."}],"balance_after":16079,"source":{"system":"sec-edgar","filing":"0000939767-26-000084","document":"wk-form4_1780527116.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976726000084/wk-form4_1780527116.xml","form_type":"4"}},{"id":759301,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":41984,"kind":"person","name":"Eckhardt Sue Gail","position":1,"cik":"0001823769","reported_name":"Eckhardt Sue Gail","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-29T21:43:42.000Z","date":"2026-05-27","kind":"grant","planned":false,"acquired":true,"shares":8367,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\") granted to the Reporting Person on the Transaction Date pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan. Each RSU is the economic equivalent of\none share of Exelixis, Inc. common stock (\"Common Stock\"). The RSUs will vest as to 100% of the shares subject to the RSU award on May 27, 2027, subject to the Reporting Person's continuous\nservice through that date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 16,079 shares of Common Stock that will be issued to the Reporting Person upon vesting of RSUs."}],"balance_after":25891,"source":{"system":"sec-edgar","filing":"0000939767-26-000081","document":"wk-form4_1780091018.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976726000081/wk-form4_1780091018.xml","form_type":"4"}},{"id":898441,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":41984,"kind":"person","name":"Eckhardt Sue Gail","position":1,"cik":"0001823769","reported_name":"Eckhardt Sue Gail","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-02-19T01:49:09.000Z","date":"2026-02-13","kind":"sale","planned":true,"acquired":false,"shares":3856,"price":43.79,"value":168854.24,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $42.89 to $43.89. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 17,524 shares of Exelixis, Inc. common stock (\"Common Stock\") that will be issued to the Reporting Person upon vesting of restricted stock units (\"RSUs\"). Each RSU is the economic\nequivalent of one share of Common Stock."}],"balance_after":17524,"source":{"system":"sec-edgar","filing":"0000939767-26-000025","document":"wk-form4_1771465747.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976726000025/wk-form4_1771465747.xml","form_type":"4"}},{"id":1123658,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":41984,"kind":"person","name":"Eckhardt Sue Gail","position":1,"cik":"0001823769","reported_name":"Eckhardt Sue Gail","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-04T23:57:38.000Z","date":"2025-06-02","kind":"sale","planned":true,"acquired":false,"shares":4,"price":43.67,"value":174.68,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on October 30, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 21,380 shares of Exelixis, Inc. common stock (\"Common Stock\") that will be issued to the Reporting Person upon vesting of restricted stock units (\"RSUs\").  Each RSU is the economic equivalent of one share of Common Stock."}],"balance_after":21380,"source":{"system":"sec-edgar","filing":"0000939767-25-000099","document":"wk-form4_1749081453.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976725000099/wk-form4_1749081453.xml","form_type":"4"}},{"id":1123657,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":41984,"kind":"person","name":"Eckhardt Sue Gail","position":1,"cik":"0001823769","reported_name":"Eckhardt Sue Gail","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-04T23:57:38.000Z","date":"2025-06-02","kind":"sale","planned":true,"acquired":false,"shares":18834,"price":42.74,"value":804965.16,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on October 30, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $42.48 to $43.33. Reporting Person undertakes to provide Exelixis, Inc., any security\nholder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in\nfootnote 2 to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 21,380 shares of Exelixis, Inc. common stock (\"Common Stock\") that will be issued to the Reporting Person upon vesting of restricted stock units (\"RSUs\").  Each RSU is the economic equivalent of one share of Common Stock."}],"balance_after":21384,"source":{"system":"sec-edgar","filing":"0000939767-25-000099","document":"wk-form4_1749081453.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976725000099/wk-form4_1749081453.xml","form_type":"4"}},{"id":1129776,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":41984,"kind":"person","name":"Eckhardt Sue Gail","position":1,"cik":"0001823769","reported_name":"Eckhardt Sue Gail","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-30T23:12:36.000Z","date":"2025-05-29","kind":"grant","planned":false,"acquired":true,"shares":9812,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\") granted to the Reporting Person on the Transaction Date pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan. Each RSU is the economic equivalent of one share of Exelixis, Inc. common stock (\"Common Stock\"). The RSUs will vest as to 100% of the shares subject to the RSU award on May 29, 2026, subject to the Reporting Person's continuous service through that date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 40,218 shares of Common Stock that will be issued to the Reporting Person upon vesting of RSUs."}],"balance_after":40218,"source":{"system":"sec-edgar","filing":"0000939767-25-000087","document":"wk-form4_1748646733.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976725000087/wk-form4_1748646733.xml","form_type":"4"}},{"id":1261805,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":41984,"kind":"person","name":"Eckhardt Sue Gail","position":1,"cik":"0001823769","reported_name":"Eckhardt Sue Gail","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (right to buy)","published_at":"2025-02-20T01:31:05.000Z","date":"2025-02-14","kind":"exercise","planned":true,"acquired":false,"shares":7712,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option, representing the right to purchase a total of 30,848 shares of Common Stock, became fully exercisable on January 5, 2024."}],"balance_after":23136,"derivative":{"exercise_price":23.24,"exercise_date":"2024-01-05","expiration_date":"2031-01-04","underlying":"Common Stock","underlying_shares":7712},"source":{"system":"sec-edgar","filing":"0000939767-25-000020","document":"wk-form4_1740015059.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976725000020/wk-form4_1740015059.xml","form_type":"4"}},{"id":1261804,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":41984,"kind":"person","name":"Eckhardt Sue Gail","position":1,"cik":"0001823769","reported_name":"Eckhardt Sue Gail","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-02-20T01:31:05.000Z","date":"2025-02-14","kind":"sale","planned":true,"acquired":false,"shares":3856,"price":35.04,"value":135114.24,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $34.95 to $35.20. Reporting Person undertakes to provide Exelixis, Inc., any security\nholder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in\nfootnote 3 to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 30,406 shares of Exelixis, Inc. common stock (\"Common Stock\") that will be issued to the Reporting Person upon vesting of restricted stock units (\"RSUs\"). Each RSU is the economic\nequivalent of one share of Common Stock."}],"balance_after":30406,"source":{"system":"sec-edgar","filing":"0000939767-25-000020","document":"wk-form4_1740015059.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976725000020/wk-form4_1740015059.xml","form_type":"4"}},{"id":1261803,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":41984,"kind":"person","name":"Eckhardt Sue Gail","position":1,"cik":"0001823769","reported_name":"Eckhardt Sue Gail","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-02-20T01:31:05.000Z","date":"2025-02-14","kind":"sale","planned":true,"acquired":false,"shares":7712,"price":35.01,"value":269997.12,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $34.37 to $35.23. Reporting Person undertakes to provide Exelixis, Inc., any security\nholder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in\nfootnote 2 to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 30,406 shares of Exelixis, Inc. common stock (\"Common Stock\") that will be issued to the Reporting Person upon vesting of restricted stock units (\"RSUs\"). Each RSU is the economic\nequivalent of one share of Common Stock."}],"balance_after":34262,"source":{"system":"sec-edgar","filing":"0000939767-25-000020","document":"wk-form4_1740015059.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976725000020/wk-form4_1740015059.xml","form_type":"4"}},{"id":1261802,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":41984,"kind":"person","name":"Eckhardt Sue Gail","position":1,"cik":"0001823769","reported_name":"Eckhardt Sue Gail","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-02-20T01:31:05.000Z","date":"2025-02-14","kind":"exercise","planned":true,"acquired":true,"shares":7712,"price":23.24,"value":179226.88,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 30,406 shares of Exelixis, Inc. common stock (\"Common Stock\") that will be issued to the Reporting Person upon vesting of restricted stock units (\"RSUs\"). Each RSU is the economic\nequivalent of one share of Common Stock."}],"balance_after":41974,"source":{"system":"sec-edgar","filing":"0000939767-25-000020","document":"wk-form4_1740015059.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976725000020/wk-form4_1740015059.xml","form_type":"4"}},{"id":1486196,"issuer":{"id":85437,"kind":"organization","name":"Syros Pharmaceuticals, Inc.","symbol":"SYRS"},"owners":[{"id":41984,"kind":"person","name":"Eckhardt Sue Gail","position":1,"cik":"0001823769","reported_name":"Eckhardt Sue Gail","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-07T16:30:12.000Z","date":"2024-06-05","kind":"grant","planned":false,"acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option becomes exercisable as to 50% of the shares underlying the award on the six month anniversary of the date of grant, with the remainder vesting in equal monthly installments of 8.33% of the shares underlying the award until the first anniversary of the date of grant, subject to the reporting person's continued service as a director through each applicable vesting date."}],"balance_after":6000,"derivative":{"exercise_price":5.3,"expiration_date":"2034-06-04","underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0000950170-24-070713","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1556263/000095017024070713/ownership.xml","form_type":"4"}},{"id":1486195,"issuer":{"id":85437,"kind":"organization","name":"Syros Pharmaceuticals, Inc.","symbol":"SYRS"},"owners":[{"id":41984,"kind":"person","name":"Eckhardt Sue Gail","position":1,"cik":"0001823769","reported_name":"Eckhardt Sue Gail","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-07T16:30:12.000Z","date":"2024-06-05","kind":"grant","planned":false,"acquired":true,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":16000,"source":{"system":"sec-edgar","filing":"0000950170-24-070713","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1556263/000095017024070713/ownership.xml","form_type":"4"}},{"id":1493558,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":41984,"kind":"person","name":"Eckhardt Sue Gail","position":1,"cik":"0001823769","reported_name":"Eckhardt Sue Gail","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-05T00:19:51.000Z","date":"2024-05-31","kind":"grant","planned":false,"acquired":true,"shares":18838,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Represents restricted stock units (\"RSUs\") granted to the Reporting Person on the Transaction Date pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan. The RSUs will vest as to 100% of the shares subject to the RSU award on May 31, 2025, subject to the Reporting Person's continuous service through that date."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\") granted to the Reporting Person on the Transaction Date pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan. The RSUs will vest as to 100% of the shares subject to the RSU award on May 31, 2025, subject to the Reporting Person's continuous service through that date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 34,262 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of RSUs. Each RSU is the economic equivalent of one share of Exelixis, Inc. common stock."}],"balance_after":34262,"source":{"system":"sec-edgar","filing":"0000939767-24-000096","document":"wk-form4_1717546784.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976724000096/wk-form4_1717546784.xml","form_type":"4"}},{"id":1683210,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":41984,"kind":"person","name":"Eckhardt Sue Gail","position":1,"cik":"0001823769","reported_name":"Eckhardt Sue Gail","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (right to buy)","published_at":"2024-01-10T02:08:52.000Z","date":"2024-01-05","kind":"grant","planned":false,"acquired":true,"shares":30848,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Option granted pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan. The option is exercisable immediately, subject to repurchase provisions, and will vest as to 1/4th of the original number of shares subject to the option on the one-year anniversary of the Transaction Date, and thereafter as to 1/48th of the original number of shares subject to the option on each monthly anniversary of the Transaction Date, subject to the Reporting Person's continuous service through such dates."}],"balance_after":30848,"derivative":{"exercise_price":23.24,"exercise_date":"2024-01-05","expiration_date":"2031-01-04","underlying":"Common Stock","underlying_shares":30848},"source":{"system":"sec-edgar","filing":"0000939767-24-000010","document":"wk-form4_1704852521.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976724000010/wk-form4_1704852521.xml","form_type":"4"}},{"id":1683209,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":41984,"kind":"person","name":"Eckhardt Sue Gail","position":1,"cik":"0001823769","reported_name":"Eckhardt Sue Gail","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-01-10T02:08:52.000Z","date":"2024-01-05","kind":"grant","planned":false,"acquired":true,"shares":15424,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Each restricted stock unit is the economic equivalent of one share of Exelixis, Inc. common stock."},{"field":"date","element":"transactionDate","label":"F2","text":"The restricted stock units were granted to the Reporting Person on the Transaction Date pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan. The restricted stock units will vest as to 1/4th of the original number of shares subject to the restricted stock unit award on each of the first four anniversaries of the Transaction Date, subject to the Reporting Person's continuous service through such dates."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 15,424 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":15424,"source":{"system":"sec-edgar","filing":"0000939767-24-000010","document":"wk-form4_1704852521.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976724000010/wk-form4_1704852521.xml","form_type":"4"}},{"id":1869136,"issuer":{"id":85437,"kind":"organization","name":"Syros Pharmaceuticals, Inc.","symbol":"SYRS"},"owners":[{"id":41984,"kind":"person","name":"Eckhardt Sue Gail","position":1,"cik":"0001823769","reported_name":"Eckhardt Sue Gail","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-02T16:24:22.000Z","date":"2023-06-01","kind":"grant","planned":false,"acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option becomes exercisable as to 50% of the shares underlying the award on the six month anniversary of the date of grant, with the remainder vesting in equal monthly installments of 8.33% of the shares underlying the award until the first anniversary of the date of grant, subject to the reporting person's continued service as a director through each applicable vesting date."}],"balance_after":6000,"derivative":{"exercise_price":3.7,"expiration_date":"2033-05-31","underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001209191-23-033720","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1556263/000120919123033720/doc4.xml","form_type":"4"}},{"id":1869135,"issuer":{"id":85437,"kind":"organization","name":"Syros Pharmaceuticals, Inc.","symbol":"SYRS"},"owners":[{"id":41984,"kind":"person","name":"Eckhardt Sue Gail","position":1,"cik":"0001823769","reported_name":"Eckhardt Sue Gail","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-02T16:24:22.000Z","date":"2023-06-01","kind":"grant","planned":false,"acquired":true,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":12000,"source":{"system":"sec-edgar","filing":"0001209191-23-033720","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1556263/000120919123033720/doc4.xml","form_type":"4"}},{"id":2155062,"issuer":{"id":85437,"kind":"organization","name":"Syros Pharmaceuticals, Inc.","symbol":"SYRS"},"owners":[{"id":41984,"kind":"person","name":"Eckhardt Sue Gail","position":1,"cik":"0001823769","reported_name":"Eckhardt Sue Gail","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-09-19T17:09:23.000Z","date":"2022-09-16","kind":"grant","acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option becomes exercisable as to 16.66% of the shares underlying the award on the six month anniversary of the date of grant, with the remainder vesting in equal monthly installments until the third anniversary of the date of grant, subject to the reporting person's continued service as a director through each applicable vesting date. Amounts reported in this Form 4 reflect the 1-for-10 reverse stock split effected by the issuer on September 16, 2022."}],"balance_after":12000,"derivative":{"exercise_price":7.349,"expiration_date":"2032-09-15","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001209191-22-050551","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1556263/000120919122050551/doc4.xml","form_type":"4"}},{"id":2155061,"issuer":{"id":85437,"kind":"organization","name":"Syros Pharmaceuticals, Inc.","symbol":"SYRS"},"owners":[{"id":41984,"kind":"person","name":"Eckhardt Sue Gail","position":1,"cik":"0001823769","reported_name":"Eckhardt Sue Gail","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-09-19T17:09:23.000Z","date":"2022-09-16","kind":"grant","acquired":true,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":8000,"source":{"system":"sec-edgar","filing":"0001209191-22-050551","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1556263/000120919122050551/doc4.xml","form_type":"4"}},{"id":2247011,"issuer":{"id":85437,"kind":"organization","name":"Syros Pharmaceuticals, Inc.","symbol":"SYRS"},"owners":[{"id":41984,"kind":"person","name":"Eckhardt Sue Gail","position":1,"cik":"0001823769","reported_name":"Eckhardt Sue Gail","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-02T19:07:06.000Z","date":"2022-06-01","kind":"grant","acquired":true,"shares":17500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option becomes exercisable as to 50% of the shares underlying the award on the six month anniversary of the date of grant, with the remainder vesting in equal monthly installments until the first anniversary of the date of grant, subject to the reporting person's continued service as a director through each applicable vesting date."}],"balance_after":17500,"derivative":{"exercise_price":0.78,"expiration_date":"2032-05-31","underlying":"Common Stock","underlying_shares":17500},"source":{"system":"sec-edgar","filing":"0001209191-22-033706","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1556263/000120919122033706/doc4.xml","form_type":"4"}},{"id":2673414,"issuer":{"id":85437,"kind":"organization","name":"Syros Pharmaceuticals, Inc.","symbol":"SYRS"},"owners":[{"id":41984,"kind":"person","name":"Eckhardt Sue Gail","position":1,"cik":"0001823769","reported_name":"Eckhardt Sue Gail","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-10T17:27:47.000Z","date":"2021-06-08","kind":"grant","acquired":true,"shares":17500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option becomes exercisable as to 50% of the shares underlying the award on the six month anniversary of the date of grant, with the remainder vesting in equal monthly installments until the first anniversary of the date of grant, subject to the reporting person's continued service as a director through each applicable vesting date."}],"balance_after":17500,"derivative":{"exercise_price":6.3,"expiration_date":"2031-06-07","underlying":"Common Stock","underlying_shares":17500},"source":{"system":"sec-edgar","filing":"0001209191-21-039574","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1556263/000120919121039574/doc4.xml","form_type":"4"}},{"id":3035114,"issuer":{"id":85437,"kind":"organization","name":"Syros Pharmaceuticals, Inc.","symbol":"SYRS"},"owners":[{"id":41984,"kind":"person","name":"Eckhardt Sue Gail","position":1,"cik":"0001823769","reported_name":"Eckhardt Sue Gail","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-09-09T08:51:49.000Z","date":"2020-09-08","kind":"grant","acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option becomes exercisable as to 16.66% of the shares underlying the award on the six month anniversary of the date of grant, with the remainder vesting in equal monthly installments until the third anniversary of the date of grant, subject to the reporting person's continued service as a director through each applicable vesting date."}],"balance_after":35000,"derivative":{"exercise_price":8.94,"expiration_date":"2030-09-07","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001209191-20-049803","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1556263/000120919120049803/doc4.xml","form_type":"4"}}]}